Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

330
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
330
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

962
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
962
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

552
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
552
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

655
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
655
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

296
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
296
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.8K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and OECD-Guided Experimental Validation of Eigenvalue-Based QSAR Models for Skin Permeation.

Journal of applied toxicology : JAT·2026
Same author

Complementary cross-gated fusion framework for brain tumor segmentation using MR images (CoGFu Net).

Journal of neuroscience methods·2026
Same author

Enhancing tuberculosis care in the private sector: Role of innovative private sector engagement model under programmatic settings in India.

PLOS global public health·2026
Same author

Therapeutic Outcomes of Aloe vera Gel Compared with Triamcinolone Acetonide in Minor Aphthous Stomatitis.

Nigerian journal of clinical practice·2026
Same author

Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study.

BMJ global health·2026
Same author

Modelling aerosol evolution under quiescent and turbulent conditions using a coupled fluid-particle dynamics solver incorporating fractal morphology.

Scientific reports·2026

Related Experiment Video

Updated: Nov 26, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Paradigm shift in efforts to end TB by 2025.

K S Sachdeva1, Malik Parmar2, Raghuram Rao1

  • 1Central TB Division, Ministry of Health & Family Welfare, Government of India, New Delhi, India.

The Indian Journal of Tuberculosis
|December 14, 2020
PubMed
Summary

This article reviews the evolution of India's Tuberculosis (TB) control programs, highlighting advancements in diagnostics, drugs, and public health initiatives. These efforts, including the National Tuberculosis Elimination Program (NTEP), aim to eradicate TB by 2025.

Keywords:
NTEPParadigmPolicyTuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

715

Related Experiment Videos

Last Updated: Nov 26, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.1K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

715

Area of Science:

  • Public Health
  • Infectious Disease Control
  • Medical History

Background:

  • Tuberculosis (TB) has been a persistent global health challenge throughout history.
  • India has progressively evolved its TB control strategies, from the National Tuberculosis Control Program (NTCP) to the Revised National Tuberculosis Control Program (RNTCP) and now the National Tuberculosis Elimination Program (NTEP).

Observation:

  • Significant progress has been made through increased funding, development of new drugs and diagnostics, improved healthcare access, and enhanced public health education.
  • The proactive involvement of TB activism, media, private sector, political advocacy, and community engagement has been crucial.
  • Ongoing vaccine trials offer renewed hope for a breakthrough in TB eradication efforts.

Findings:

  • The current National Tuberculosis Elimination Program (NTEP) incorporates a paradigm shift in policy, emphasizing population-based vulnerability mapping and active case-finding.
  • These strategies are expected to accelerate India's progress towards achieving TB elimination goals.

Implications:

  • Continued investment in research, innovation, and the development of more effective drugs and vaccines is essential.
  • These advancements will strengthen the global armamentarium against TB, bringing the goal of ending TB within reach.